The hospital is a multi-specialty center with more than 50 clinical specialties available and with over 1,340 beds. It
is widely regarded as the most celebrated hospital in the country and among the most reputable medical centers
in Europe. San Raffaele’s wards and operating theatres are equipped with the most advanced machines, such as
PET, PET/CT, Gamma Knife, Cyber Knife, Rapid Arc, Tomotherapy. San Raffaele’s Radiotherapy Unit was the first place
in Europe to install Tomotherapy in 2004. Nowadays this Unit confirms to be one of the most experienced worldwide;
it has developed numerous protocols for cancer treatment of the prostate, breast, central nervous system,
brain, liver, pancreas, gastrointestinal tract, lungs, and others. The Oncological Board of the Hospital consisting of
diagnosticians, clinical oncologists, immunologists, surgeons and radiotherapists, hold weekly meetings to discuss
oncological patients’ pathways in a multidisciplinary manner.
San Raffaele is a pioneer in the field of gene medicine and treatment of rare immunologic and genetic diseases.
San Raffaele Scientific Institute is where the first in the world gene therapy with stem cells was created, named
Strimvelis, for patients affected by ADA-SCID syndrome.
The Research at the San Raffaele Hospital focuses on integrating basic, translational and clinical research to provide
the most advanced care to the patients. It counts on over 1,500 scientists, working in state-of-the-art facilities have
produced over 1,446 scientific publications in 2018. Research at San Raffaele aims at understanding the mechanisms
underlying a variety of important human diseases and at identifying new targets and new therapeutic
strategies to treat them.